Banting, F. G., Best, C. H., Collip, J. B., Campbell, W. R. & Fletcher, A. A. Pancreatic extracts in the treatment of diabetes mellitus. Can. Med. Assoc. J. 12, 141–146 (1922).

CAS  PubMed  PubMed Central  Google Scholar 

Kimball, C. & Murlin, J. R. Aqueous extracts of pancreas III. Some precipitation reactions of insulin. J. Biol. Chem. 58, 337–346 (1923).

Article  CAS  Google Scholar 

Sutherland, E. W. & Cori, C. F. Purification of the hyperglycemic-glycogenolytic factor from insulin and from gastric mucosa. J. Biol. Chem. 180, 825–837 (1949).

Article  CAS  PubMed  Google Scholar 

Unger, R. & Orci, L. The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet 305, 14–16 (1975).

Article  Google Scholar 

Cherrington, A. D., Williams, P. E., Shulman, G. I. & Lacy, W. W. Differential time course of glucagon’s effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes 30, 180–187 (1981).

Article  CAS  PubMed  Google Scholar 

Magnusson, I., Rothman, D. L., Gerard, D. P., Katz, L. D. & Shulman, G. I. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes 44, 185–189 (1995).

Article  CAS  PubMed  Google Scholar 

Bonner-Weir, S., Sullivan, B. A. & Weir, G. C. Human islet morphology revisited: human and rodent islets are not so different after all. J. Histochem. Cytochem. 63, 604–612 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Unger, R. H., Eisentraut, A. M., McCall, M. S. & Madison, L. L. Glucagon antibodies and an immunoassay for glucagon. J. Clin. Invest. 40, 1280–1289 (1961).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holst, J. J. & Albrechtsen, N. J. W. Methods and guidelines for measurement of glucagon in plasma. Int. J. Mol. Sci. 20, 5416 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muller, W., Faloona, G., Aguilar-Parada, E. & Unger, R. Abnormal alpha-cell function in diabetes — response to carbohydrate and protein ingestion. N. Engl. J. Med. 283, 109–115 (1970).

Article  CAS  PubMed  Google Scholar 

Sasaki, H. et al. Identification of glucagon in the gastrointestinal tract. J. Clin. Invest. 56, 135–145 (1975).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wewer Albrechtsen, N. J. et al. Circulating glucagon 1-61 regulates blood glucose by increasing insulin secretion and hepatic glucose production. Cell Rep. 21, 1452–1460 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holst, J. J., Albrechtsen, N. J. W., Gabe, M. B. N. & Rosenkilde, M. M. Oxyntomodulin: actions and role in diabetes. Peptides 100, 48–53 (2018).

Article  CAS  PubMed  Google Scholar 

Lund, A. et al. Evidence of extrapancreatic glucagon secretion in man. Diabetes 65, 585–597 (2016).

Article  CAS  PubMed  Google Scholar 

Jorsal, T. et al. Investigating intestinal glucagon after Roux-en-Y gastric bypass surgery. J. Clin. Endocrinol. Metab. 104, 6403–6416 (2019).

Article  PubMed  Google Scholar 

Lund, A. & Knop, F. K. Extrapancreatic glucagon: present status. Diabetes Res. Clin. Pract. 147, 19–28 (2019).

Article  CAS  PubMed  Google Scholar 

Kilimnik, G., Kim, A., Steiner, D. F., Friedman, T. C. & Hara, M. Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of β-cell regeneration. Islets 2, 149–155 (2010).

Article  PubMed  Google Scholar 

Marchetti, P. et al. A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia 55, 3262–3272 (2012).

Article  CAS  PubMed  Google Scholar 

Knop, F. K. Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia 52, 2270–2276 (2009).

Article  CAS  PubMed  Google Scholar 

Jorsal, T. et al. Enteroendocrine K and L cells in healthy and type 2 diabetic individuals. Diabetologia 61, 284–294 (2018).

Article  CAS  PubMed  Google Scholar 

Thim, L. & Moody, A. J. The amino acid sequence of porcine glicentin. Peptides 2, 37–39 (1981).

Article  CAS  PubMed  Google Scholar 

Bataille, D. et al. Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities. Peptides 2, 41–44 (1981).

Article  CAS  PubMed  Google Scholar 

Holst, J. J. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem. J. 207, 381–388 (1982).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wewer Albrechtsen, N. J. et al. Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? Diabetologia 57, 1919–1926 (2014).

Article  CAS  PubMed  Google Scholar 

Wewer Albrechtsen, N. J. et al. Inability of some commercial assays to measure suppression of glucagon secretion. J. Diabetes Res. 2016, 8352957 (2016).

Article  PubMed  Google Scholar 

Svoboda, M., Tastenoy, M., Vertongen, P. & Robberecht, P. Relative quantitative analysis of glucagon receptor mRNA in rat tissues. Mol. Cell. Endocrinol. 105, 131–137 (1994).

Article  CAS  PubMed  Google Scholar 

Hansen, L. H., Abrahamsen, N. & Nishimura, E. Glucagon receptor mRNA distribution in rat tissues. Peptides 16, 1163–1166 (1995).

Article  CAS  PubMed  Google Scholar 

Watanabe, M., Hayasaki, H., Tamayama, T. & Shimada, M. Insulin and glucagon receptor distribution. Braz. J. Med. Biol. Res. 31, 243–256 (1998).

Article  CAS  PubMed  Google Scholar 

van der Woning, B. et al. DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops. mAbs 8, 1126–1135 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Jiang, G. & Zhang, B. B. Glucagon and regulation of glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 284, 671–678 (2003).

Article  Google Scholar 

Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D. & Tschöp, M. H. The new biology and pharmacology of glucagon. Physiol. Rev. 97, 721–766 (2017).

Article  PubMed  Google Scholar 

Galsgaard, K. D., Pedersen, J., Knop, F. K., Holst, J. J. & Albrechtsen, N. J. W. Glucagon receptor signaling and lipid metabolism. Front. Physiol. 10, 413 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Richter, W. O., Robl, H. & Schwandt, P. Human glucagon and vasoactive intestinal polypeptide (VIP) stimulate free fatty acid release from human adipose tissue in vitro. Peptides 10, 333–335 (1989).

Article  CAS  PubMed  Google Scholar 

Wu, M. S. et al. Does glucagon increase plasma free fatty acid concentration in humans with normal glucose tolerance? J. Clin. Endocrinol. Metab. 70, 410–416 (1990).

Article  CAS  PubMed  Google Scholar 

Jensen, M. D., Heiling, V. J. & Miles, J. M. Effects of glucagon on free fatty acid metabolism in humans. J. Clin. Endocrinol. Metab. 72, 308–315 (1991).

Article  CAS  PubMed  Google Scholar 

Højbjerg Gravholt, C., Møller, N., Jensen, M. D., Christiansen, J. S. & Schmitz, O. Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis. J. Clin. Endocrinol. Metab. 86, 2085–2089 (2001).

Google Scholar 

Xiao, C., Pavlic, M., Szeto, L., Patterson, B. W. & Lewis, G. F. Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humans. Diabetes 60, 383–390 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Longuet, C. et al. The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab. 8, 359–371 (2008).

Article  CAS  PubMed  PubMed Central